U.S. stocks were lower, with the Dow Jones index falling around 0.1% on Tuesday. Shares of Novo Nordisk A/S (NYSE:NVO) rose sharply during Tuesday's session following FDA approval of its Wegovy pill. Novo Nordisk received approval from the U.S. Food and Drug Administration for its GLP-1 pill,…
Continue reading...